Next Generation Labs Granted Australian Patent for the Use of...

The use of combinational and variable isomeric ratios of R and S synthetic nicotine may ultimately assist adults in quitting or reducing their overall dependence on tobacco.(PRWeb July 22, 2021)Read the full story at https://www.prweb.com/releases/next_generation_labs_granted_australian_patent_for_the_use_of_tfn_combinational_r_and_s_isomer_synthetic_nicotine_in_tobacco_cessation_products/prweb18086972.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news